MedTrace Logo

The MAGiC™ Cardiac Ablation European Study

NCT06019845 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-05-04

No results posted yet for this study

Summary

The purpose of the first phase of this feasibility study is to gather safety and performance data on MAGiC to support European marketing approval.

The purpose of MAGiC-FEST PMCF Study is to collect safety and performance data with MAGiC to meet ongoing regulatory obligations.

Conditions

  • Arrhythmias, Cardiac

Interventions

DEVICE

MAGiC™

Robotic magnetic radiofrequency (RF) ablation catheter

Sponsors & Collaborators

  • Osypka AG

    collaborator UNKNOWN

  • Stereotaxis

    lead INDUSTRY

Principal Investigators

  • Betsy Lowry · Stereotaxis

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-02
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • Denmark
  • Lithuania
  • Netherlands
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06019845 on ClinicalTrials.gov